Adding Evidence to
Healthcare Innovation.

Medical advances in history: Vaccines, Anaesthetics, Germ therapy, Medical Imaging, Antibiotics, Organ Transplants, Antiviral Drugs, Stem Cell Therapy, Immunotherapy. Innovations that are expected to revolutionize healthcare: AI, 3D Printing, CRISPR Gene Editing, Virtual Reality, Smart Bandages.

Innovation in healthcare encompasses a broad range of applications from novel therapies, surgical procedures, tools, tests, to new approaches to training, education, procurement, and service delivery models. Multiple factors such as an aging population, sharp rises in long term conditions, reduced funding, increased patient expectations, the threat of pandemics, and the shortages in the availability of skilled staff highlight a constant need for innovation in healthcare. Since healthcare systems are struggling to make the most of innovations, it is crucial to understand the features of an innovation, the characteristics of its potential adopters, and the implementation process.

We support you in strengthening your understanding of the features that are important for the adoption of your innovation.

It is frequently stated that the discovery-to-practice gap in healthcare averages 17 years. The need to move faster is recognised by many. With the call for speed comes the question: what factors influence speed?

With different needs of information in the various phases of the innovation-decision model and the challenge to go fast but not do harm, it is of utmost importance to obtain the right level of evidence to facilitate informed decision making during the innovation cycle. For example, for a stakeholder to form an attitude about an innovation, information about its relative advantage, its compatibility with current beliefs and practices, its complexity, how easy it is to try, and whether one can watch someone using it all contribute to the decision to (not) adopt an innovation.

We support you in obtaining the required evidence for your innovation to support its timely translation into practice.

The challenge of our time is to simultaneously improve health and care equity, improve population health, reduce cost of care, enhance the patient experience, and improve provider satisfaction.

When it comes to innovation, what and how you measure matters. Metrics must be tailored to the goals of innovation and dependent on the type of efforts put forward. After all, innovation can spread, run as expected, diminish in scope, or even stop, and innovation can demonstrate higher than expected value, value as expected, or lower than expected value. As part of the innovation-decision cycle, stakeholders continuously judge the credibility of evidence.

We apply in-depth and comprehensive competencies in theory and research methods to help thrive your innovation and achieve improvements for individuals, organisations, networks, and systems in different contexts.

Let us support you in making your innovation count.

What others say about Panaxea

  • Adding health economic evidence to healthcare innovation.
    “Panaxea’s contribution to the EU project Automated Cell Robot-Assisted Technology has been critical in assessing ultimate societal and economic benefits.”
    Prof. Mary Murphy|Professor of Regenerative Medicine at the Regenerative Medicine Institute, National University of Ireland, Galway
  • Help to achieve improvements for individuals & organisations
    “I wish to express my endorsement of Panaxea for its exceptional contributions in teaching of Realist Evaluation (RE) to the SingHealth community through workshops and mentorship programmes since 2021. Through his educational workshops, Professor Vrijhoef has demystified the intricacies of RE so that participants could readily relate it to relevant population health contexts. His mentorship and support were also invaluable as he nurtured our staff in their respective RE project journeys.”
    Oh Hong Choon|PhD, Deputy Director Centre for Population Health Research & Implementation Singapore Health Services Pte Ltd (SingHealth)
  • Extensive expertise in research
    "The European Specialist Nurses Organisation (ESNO) and Panaxea have been partnering on various projects since 2018, with Panaxea being one of the members of the recently initiated ESNO Consortium of selected organizations. The team at Panaxea understands our needs regarding informed decision making, for example about health workforce challenges, extremely well. They have extensive expertise in how to conduct research in the evolving and strategic field of specialist nurses in Europe and how to translate research findings into useful recommendations."
    Ber Oomen|CEO/Executive Director ESNO

Cases & Publications

all cases & publications